Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae

Innate Immunity

Volumn 20, Issue 4, 2014, Pages 350-363

  Velkov, Tony ^a   Deris, Zakuan Z ^a,b   Huang, Johnny X ^c   Azad, Mohammad A K ^a   Butler, Mark ^c   Sivanesan, Sivashangarie ^a   Kaminskas, Lisa M ^a   Dong, Yao Da ^a   Boyd, Ben ^a   Baker, Mark A ^d   Cooper, Matthew A ^c   Nation, Roger L ^a   Li, Jian ^a  

^a MONASH UNIVERSITY   (Australia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

colistin; Klebsiella pneumoniae; lipopolysaccharide; Polymyxin; surface

Indexed keywords

1 NAPHTHYLAMINE; ANTIINFECTIVE AGENT; COLISTIN; DEOXYCHOLIC ACID; LIPOPOLYSACCHARIDE; LYSOZYME; N-PHENYL-1-NAPHTHYLAMINE; OUTER MEMBRANE PROTEIN; POLYMYXIN B; PROTEIN BINDING;

ANALOGS AND DERIVATIVES; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECTS; DRUG INTERACTION; DRUG RESISTANCE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MEMBRANE POTENTIAL; METABOLISM; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; SPECIES DIFFERENCE; STATIC ELECTRICITY;

1-NAPHTHYLAMINE; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; COLISTIN; DEOXYCHOLIC ACID; DRUG INTERACTIONS; DRUG RESISTANCE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIPOPOLYSACCHARIDES; MEMBRANE POTENTIALS; MICROBIAL SENSITIVITY TESTS; MURAMIDASE; POLYMYXIN B; PROTEIN BINDING; SPECIES SPECIFICITY; STATIC ELECTRICITY;

EID: 84898983354     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425913493337     Document Type: Article

References (69)

1. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998 ; 11: 589-603
2. Gasink LB, Edelstein PH, Lautenbach E, et al. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009 ; 30: 1180-1185
3. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011 ; 11: 355-362
4. Sidjabat H, Nimmo GR, Walsh TR, et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-beta-lactamase. Clin Infect Dis. 2011 ; 52: 481-484
5. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2011 ; 10: 597-602
6. Zavascki AP, Goldani LZ, Li J, Nation RL. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother. 2007 ; 60: 1206-1215
7. Gales AC, Jones RN, Sader HS. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect. 2006 ; 12: 315-321
8. Gales AC, Jones RN, Sader HS. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09). J Antimicrob Chemother. 2011 ; 66: 2070-2074
9. Bratu S, Tolaney P, Karumudi U, et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother. 2005 ; 56: 128-132
10. Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. Clin Infect Dis. 2009 ; 49: 271-274
11. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev. 2003 ; 67: 593-656
12. Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother. 1989 ; 33: 1831-1836
13. Brade H, Opal SM, Vogel SN, Morrison DC Endotoxin in health and disease. New York: Marcel Dekker ; 1999 :
14. Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem. 2002 ; 71: 635-700
15. Vinogradov E, Frirdich E, MacLean LL, et al. Structures of lipopolysaccharides from Klebsiella pneumoniae. Eluicidation of the structure of the linkage region between core and polysaccharide O chain and identification of the residues at the non-reducing termini of the O chains. J Biol Chem. 2002 ; 277: 25070-25081
16. Vinogradov E, Perry MB. Structural analysis of the core region of the lipopolysaccharides from eight serotypes of Klebsiella pneumoniae. Carbohydr Res. 2001 ; 335: 291-296
17. Clements A, Tull D, Jenney AW, et al. Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides. J Biol Chem. 2007 ; 282: 15569-15577
18. Hancock RE. The bacterial outer membrane as a drug barrier. Trends Microbiol. 1997 ; 5: 37-42
19. Llobet E, Campos MA, Gimenez P, et al. Analysis of the networks controlling the antimicrobial-peptide-dependent induction of Klebsiella pneumoniae virulence factors. Infect Immun. 2011 ; 79: 3718-3732
20. Llobet E, March C, Gimenez P, Bengoechea JA. Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides. Antimicrob Agents Chemother. 2009 ; 53: 298-302
21. Campos MA, Vargas MA, Regueiro V, et al. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun. 2004 ; 72: 7107-7114
22. Cheng HY, Chen YF, Peng HL. Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43. J Biomed Sci. 2010 ; 17: 60-60
23. Velkov T, Thompson PE, Nation RL, Li J. Structure-Activity relationships of polymyxin antibiotics. J Med Chem. 2010 ; 53: 1898-1916
24. Hancock REW, Chapple DS. Peptide antibiotics. Antimicrob Agents Chemother. 1999 ; 43: 1317-1323
25. Moore RA, Woodruff WA, Hancock RE. Antibiotic uptake pathways across the outer membrane of Pseudomonas aeruginosa. Antibiot Chemother. 1987 ; 39: 172-181
26. Hancock RE, Bell A. Antibiotic uptake into gram-negative bacteria. Eur J Clin Microbiol Infect Dis. 1988 ; 7: 713-720
27. Schröder G, Brandenburg K, Seydel U. Polymyxin B induces transient permeability fluctuations in asymmetric planar lipopolysaccharide/phospholipid bilayers. Biochemistry. 1992 ; 31: 631-638
28. Liechty A, Chen J, Jain MK. Origin of antibacterial stasis by polymyxin B in Escherichia coli. Biochim Biophys Acta. 2000 ; 1463: 55-64
29. Zhang L, Dhillon P, Yan H, et al. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000 ; 44: 3317-3321
30. Oh JT, Van Dyk TK, Cajal Y, et al. Osmotic stress in viable Escherichia coli as the basis for the antibiotic response by polymyxin B. Biochem Biophys Res Commun. 1998 ; 246: 619-623
31. Soon RL, Velkov T, Chiu F, et al. Design, synthesis and evaluation of a new fluorescent probe for measuring polymyxin-lipopolysaccharide binding interactions. Anal Biochem. 2011 ; 409: 273-283
32. Vinogradov E, Lindner B, Seltmann G, et al. Lipopolysaccharides from Serratia marcescens possess one or two 4-Amino-4-deoxy-L-Arabinopyranose 1-phosphate residues in the lipid A and D-glycero-D-talo-oct-2-ulopyranosonic acid in the inner core region. Chemistry. 2006 ; 12: 6692-6700
33. Raetz CR, Reynolds CM, Trent MS, Bishop RE. Lipid A modification systems in Gram-negative bacteria. Annu Rev Biochem. 2007 ; 76: 295-329
34. Falagas ME, Rafailidis PI, Matthaiou DK. Resistance to polymyxins: Mechanisms, frequency and treatment options. Drug Resist Updat. 2010 ; 13: 132-138
35. Loutet SA, Flannagan RS, Kooi C, et al. A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J Bacteriol. 2006 ; 188: 2073-2080
36. Mitrophanov AY, Jewett MW, Hadley TJ, Groisman EA. Evolution and dynamics of regulatory architectures controlling polymyxin B resistance in enteric bacteria. PLoS Genet. 2008 ; 4: e1000233 - e1000233
37. Helander IM, Kilpelainen I, Vaara M. Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin-resistant pmrA mutants of Salmonella typhimurium: a 31P-NMR study. Mol Microbiol. 1994 ; 11: 481-487
38. Helander IM, Kato Y, Kilpelainen I, et al. Characterization of lipopolysaccharides of polymyxin-resistant and polymyxin-sensitive Klebsiella pneumoniae O3. Eur J Biochem. 1996 ; 237: 272-278
39. Velkov T, Pei L, Chong, JX. et al. Molecular basis for the increased polymyxin susceptibility of Klebsiella pneumoniae strains with under-Acylated lipid A. Innate Immun 2013; 19(3): 265-277.
40. Li J, Milne RW, Nation RL, et al. Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography. Antimicrob Agents Chemother. 2003 ; 47: 1364-1370
41. Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008 ; 3: 163-175
42. Darveau RP, Hancock RE. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol. 1983 ; 155: 831-838
43. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 ; 227: 680-685
44. Dubray G, Bezard G. A highly sensitive periodic acid-silver stain for 1,2-diol groups of glycoproteins and polysaccharides in polyacrylamide gels. Anal Biochem. 1982 ; 119: 325-329
45. Lee CH, Tsai CM. Quantification of bacterial lipopolysaccharides by the purpald assay: measuring formaldehyde generated from 2-keto-3-deoxyoctonate and heptose at the inner core by periodate oxidation. Anal Biochem. 1999 ; 267: 161-168
46. Vaara M, Vaara T. Outer membrane permeability barrier disruption by polymyxin in polymyxin-susceptible and -resistant Salmonella typhimurium. Antimicrob Agents Chemother. 1981 ; 19: 578-583
47. Velkov T, Lim ML, Horne J, et al. Characterization of lipophilic drug binding to rat intestinal fatty acid binding protein. Mol Cell Biochem. 2009 ; 326: 87-95
48. Brandenburg K, Seydel U. Thermodynamic investigations on mono- and bilayer membrane systems made from lipid components of Gram-negative bacteria. Thermochimica Acta. 1985 ; 85: 477-480
49. Helander IM, Mattila-Sandholm T. Fluorometric assessment of Gram-negative bacterial permeabilization. J Appl Microbiol. 2000 ; 88: 213-219
50. Soon RL, Nation RL, Cockram S, et al. Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment. J Antimicrob Chemother. 66: 126-133
51. Sims PJ, Waggoner AS, Wang CH, Hoffman JF. Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles. Biochemistry. 1974 ; 13: 3315-3330
52. Hodate K, Bito Y. Temperature dependence of bactericidal action of polymyxin B. Microbiol Immunol. 1982 ; 26: 737-740
53. Brandenburg K, Andra J, Müller M, et al. Physicochemical properties of bacterial glycopolymers in relation to bioactivity. Carbohydr Res. 2003 ; 338: 2477-2489
54. Brandenburg K, Arraiza MD, Lehwark-Ivetot G, et al. The interaction of rough and smooth form lipopolysaccharides with polymyxins as studied by titration calorimetry. Thermochim Acta. 2002 ; 394: 53-61
55. Brandenburg K, David A, Howe J, et al. Temperature dependence of the binding of endotoxins to the polycationic peptides polymyxin B and its nonapeptide. Biophys J. 2005 ; 88: 1845-1858
56. Howe J, Andra J, Conde R, et al. Thermodynamic analysis of the lipopolysaccharide-dependent resistance of gram-negative bacteria against polymyxin B. Biophys J. 2007 ; 92: 2796-2805
57. Howe J, Hammer MU, Brandenburg K. Calorimetric investigations of the effect of polymyxin B on different Gram-negative bacteria. Thermochim Acta. 2007 ; 458: 34-37
58. Garidel P, Brandenburg K. Current understanding of polymyxin B applications in bacreraemia/scepsis therapy prevention: clinical, pharmaceutical, structural and mechanistic aspects. Antiinfect Agents Medic Chem. 2009 ; 8: 367-385
59. Ghazi A, Schechter E, Letellier L, Labedan B. Probes of membrane potential in Escherichia coli cells. FEBS Lett. 1981 ; 125: 197-200
60. Wu M, Maier E, Benz R, Hancock RE. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry. 1999 ; 38: 7235-7242
61. Anderson RC, Hancock RE, Yu PL. Antimicrobial activity and bacterial-membrane interaction of ovine-derived cathelicidins. Antimicrob Agents Chemother. 2004 ; 48: 673-676
62. Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother. 2003 ; 47: 2538-2544
63. Campos MA, Morey P, Bengoechea JA. Quinolones sensitize Gram-negative bacteria to antimicrobial peptides. Antimicrob Agents Chemother. 2006 ; 50: 2361-2367
64. Badley RA Modern Fluorescent Spectroscopy. Wehry EL, ed. London: Heydon ; 1976 :
65. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev. 1992 ; 56: 395-411
66. Loughlin MF, Jones MV, Lambert PA. Pseudomonas aeruginosa cells adapted to benzalkonium chloride show resistance to other membrane-Active agents but not to clinically relevant antibiotics. J Antimicrob Chemother. 2002 ; 49: 631-639
67. Malott RJ, Steen-Kinnaird BR, Lee TD, Speert DP. Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivorans. Antimicrob Agents Chemother. 2011 ; 56: 464-471
68. Kannenberg EL, Poralla K. Hopanoid biosynthesis and function in bacteria. Naturwissenschaften. 1999 ; 86: 168-176
69. Azad MA, Huang JX, Cooper MA, et al. Structure-Activity relationships for the binding of polymyxins with human alpha-1-Acid glycoprotein. Biochem Pharmacol. 2012 ; 84: 278-291